PRIORY MEDICARE LIMITED Company accounts

COMPANY REGISTRATION NUMBER: 9228607

PRIORY MEDICARE LIMITED

Unaudited Financial Statements

30 September 2024

PRIORY MEDICARE LIMITED

Financial Statements

Year ended 30 September 2024

Contents	Page

Director's report	1

Chartered certified accountants report to the director on the preparation of the unaudited statutory financial statements	2

Statement of financial position	3

Notes to the financial statements	4

PRIORY MEDICARE LIMITED

Director's Report

Year ended 30 September 2024

The director presents her report and the unaudited financial statements of the company for the year ended 30 September 2024 .

The company has been dormant as defined in section 1169 of the Companies Act 2006 throughout the year and preceding financial year. It is anticipated that the company will remain dormant for the foreseeable future.

Director

The director who served the company during the year was as follows:

Dr. A. Sirpal

Small company provisions

This report has been prepared in accordance with the provisions applicable to companies entitled to the small companies exemption.

This report was approved by the board of directors on 29 September 2025 and signed on behalf of the board by:

Dr. A. Sirpal
Director

Registered office:

c/o Vaghela & Co Services Limited

Clark's Courtyard

145 Granville Street

Birmingham

B1 1SB

PRIORY MEDICARE LIMITED

Chartered Certified Accountants Report to the Director on the Preparation of the Unaudited Statutory Financial Statements of PRIORY MEDICARE LIMITED

Year ended 30 September 2024

As described on the statement of financial position, the director of the company is responsible for the preparation of the financial statements for the year ended 30 September 2024, which comprise the statement of financial position and the related notes. You consider that the company is exempt from an audit under the Companies Act 2006. In accordance with your instructions we have compiled these financial statements in order to assist you to fulfil your statutory responsibilities, from the accounting records and from information and explanations supplied to us.

VAGHELA & CO. (SERVICES) LTD. Chartered Certified Accountants

P.O. Box 10901 Birmingham B1 1ZQ

29 September 2025

PRIORY MEDICARE LIMITED

Statement of Financial Position

30 September 2024

	2024		2023
Note	£	£	£

Current assets

Debtors	4	1,161		1,161

Creditors: amounts falling due within one year	5	965		965
		-------		-------
Net current assets			196	196
			----	----
Total assets less current liabilities			196	196

Provisions

Taxation including deferred tax	126	126
	----	----
Net assets	70	70
	----	----

Capital and reserves

Called up share capital	7	100	100
Profit and loss account		( 30)	( 30)
		----	----
Shareholders funds		70	70
		----	----

These financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with Section 1A of FRS 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'.

The company did not trade during the current year or prior year and has not made either a profit or loss.

For the year ending 30 September 2024 the company was entitled to exemption from audit under section 480 of the Companies Act 2006 relating to dormant companies.

Director's responsibilities:

- The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476 ;

- The director acknowledges her responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements .

These financial statements were approved by the board of directors and authorised for issue on 29 September 2025 , and are signed on behalf of the board by:

Dr. A. Sirpal
Director

Company registration number: 9228607

PRIORY MEDICARE LIMITED

Notes to the Financial Statements

Year ended 30 September 2024

1. General information

The company is a private company limited by shares, registered in England and Wales. The address of the registered office is c/o Vaghela & Co Services Limited, Clark's Courtyard, 145 Granville Street, Birmingham, B1 1SB.

2. Statement of compliance

These financial statements have been prepared in compliance with Section 1A of FRS 102, 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland'.

3. Accounting policies

Basis of preparation

The financial statements have been prepared on the historical cost basis, as modified by the revaluation of certain financial assets and liabilities and investment properties measured at fair value through profit or loss.

The financial statements are prepared in sterling, which is the functional currency of the entity.

Disclosure exemptions

The entity satisfies the criteria of being a qualifying entity as defined in FRS 102. As such, advantage has been taken of the following disclosure exemptions available under paragraph 1.12 of FRS 102: (a) No cash flow statement has been presented for the company. (b) Disclosures in respect of financial instruments have not been presented.

Income statement

The company is dormant as defined by section 1169 of the Companies Act 2006. The company received no income and incurred no expenditure during the current year or prior year and therefore no income statement is presented within these financial statements. There have been no movements in shareholders funds during the current year or prior year.

Income tax

Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date except that deferred tax assets are recognised only to the extent that the directors anticipate that there will be suitable taxable profits from which the future reversal of the underlying timing differences can be deducted. Deferred tax balances are not discounted.

Depreciation

Depreciation is calculated so as to write off the cost or valuation of an asset, less its residual value, over the useful economic life of that asset as follows:

	Equipment	-	20% straight line

Provisions

Provisions are recognised when the entity has an obligation at the reporting date as a result of a past event, it is probable that the entity will be required to transfer economic benefits in settlement and the amount of the obligation can be estimated reliably. Provisions are recognised as a liability in the statement of financial position and the amount of the provision as an expense. Provisions are initially measured at the best estimate of the amount required to settle the obligation at the reporting date and subsequently reviewed at each reporting date and adjusted to reflect the current best estimate of the amount that would be required to settle the obligation. Any adjustments to the amounts previously recognised are recognised in profit or loss unless the provision was originally recognised as part of the cost of an asset. When a provision is measured at the present value of the amount expected to be required to settle the obligation, the unwinding of the discount is recognised as a finance cost in profit or loss in the period it arises.

Financial instruments

Financial instruments are classified and accounted for, according to the substance of the contractual arrangement, as either financial assets, financial liabilities or equity instruments. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities.

4. Debtors

	2024	2023
	£	£
Other debtors	1,161	1,161
	-------	-------

5. Creditors: amounts falling due within one year

	2024	2023
	£	£
Social security and other taxes	65	65
Other creditors	900	900
	----	----
	965	965
	----	----

6. Deferred tax

The deferred tax included in the statement of financial position is as follows:

	2024	2023
	£	£
Included in provisions	126	126
	----	----

The deferred tax account consists of the tax effect of timing differences in respect of:

	2024	2023
	£	£
Accelerated capital allowances	126	126
	----	----

7. Called up share capital

Issued, called up and fully paid

	2024		2023
	No.	£	No.	£
Ordinary shares of £ 1 each	100	100	100	100
	----	----	----	----

8. Director's advances, credits and guarantees

At 30th September 2024, debtors include the following amounts due from the director:- Dr A. Sirpal £1,161 (2023 - £1,161 ) The loans are interest free and repayable on demand

9. Related party transactions

During the year, no advances or credits were made with the director, Dr A. Sirpal. The director, Dr A. Sirpal received no dividends for the year under review.